Focus on Diabetes Care

Back to articles

New Drugs, Delivery Systems: Research Revamping Diabetes Care


With inhaled insulin poised for marketing in the United States, diabetologists are realizing just how much change medical innovations have injected into the way they manage diabetes and its complications.



Manna TD et al. Subcutaneous use of a fast-acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care. 2005;28:1856–61.

DeFronzo RA et al. Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial. Diabetes Care. 2005;28:1922–8.

Heise T et al. The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin: a prospective randomized pharmacodynamic study. Diabetes Care. 2005;28:2161–9.